SUMMIT CMR Substudy: Tirzepatide Reduced RV Mass and Atrial Volumes in Obesity-Related HFpEF
Obesity drives heart failure with preserved ejection fraction (HFpEF) in several ways.…
IRONMET-HFpEF: A Single Dose of IV Iron Improved Exercise Capacity in HFpEF With Iron Deficiency
Poor exercise tolerance is the defining complaint of patients with heart failure…
Cleaner Air Trial: Bedroom HEPA Filtration Lowered Glycemic Variability in Adults with Prediabetes
Air pollution ranks second only to high blood pressure as a risk…
COURAGE at 25-Year: Upfront PCI Does Not Reduce Long-Term Risk of Death or MI in Stable CAD
In stable coronary artery disease (CAD), current guidelines recommend percutaneous coronary intervention…
RESOLVE-1: Oral Ruvonoflast Reduces Inflammatory Biomarkers in Phase 2 Trial
Key Points: Inflammation is mechanistically linked to atherogenesis, plaque progression, and recurrent…
HI-PRO: One Year of Low-Dose Apixaban Lowers Two-Year VTE Recurrence in Provoked Thromboembolism
Key Points: Decisions about the duration of anticoagulation after venous thromboembolism (VTE)…
CHIP-BCIS3: Periprocedural Myocardial Injury is Associated with Increased CV Death in Complex PCI
Key Points: Microaxial flow pump use has been proposed as a way…